Managing TP controversy in a smart way by using all options for dispute resolution will be key for life science companies in the coming years.

Oliver Wehnert

EY Europe West Tax Market Segment Leader, Health Science & Wellness

Supports companies in international profit allocation (transfer pricing) across the entire transfer pricing life cycle. Extensive experience in the life sciences sector, especially in pharma.

Oliver is the Tax Market Segment Leader in Europe West for Health Science & Wellness.

He has been with EY for more than 20 years and is a partner for Transfer Pricing since 2001. Oliver has extensive skills in the field of global transfer pricing - especially in international tax planning in connection with intangible assets, dispute resolution (mutual agreement procedures) and prevention (Advance Pricing Agreements (APAs); ICAP; Joint Tax Audits) as well as with Operating Model Transformation (OMT) projects. He is one of the leading German consultants in the pharma and life sciences sector.

Oliver studied business administration at the University of Paderborn. He is a business graduate and tax advisor.

How Oliver is building a better working world

“My main focus for contributing to EY’s commitment to building a better working world is to focus on our people; I am passionate about developing a flame in our people to be open-minded, and encouraging them to enjoy solving problems in the ever more complex world we are living in.”

Our latest thinking

    Contact Oliver